In short: aspirin and ibuprofen (Advil) are both NSAIDs, but long-term safety profiles differ mainly because aspirin irreversibly inhibits platelets and has a different balance of GI, cardiovascular, and renal risks. Here’s a concise comparison:
- Mechanism and what it means
- Aspirin: irreversibly inhibits COX-1 (and COX-2 to a lesser degree) in platelets, giving a lasting antiplatelet (blood-thinning) effect that can persist for the life of a platelet (about 7–10 days). This helps with some cardiovascular protection but raises bleeding risk.
- Ibuprofen: reversibly inhibits COX enzymes. Its platelet effects are short-lived; bleeding risk is present but not due to an irreversible antiplatelet action.
- GI safety (stomach and gut)
- Aspirin: generally higher risk of gastritis, ulcers, and GI bleeding, especially with long-term use, older adults, a history of ulcers, high doses, or when taken with alcohol or other anticoagulants/antiplatelets. Adding a proton pump inhibitor (PPI) can reduce risk.
- Ibuprofen:also increases GI risk, but often considered to be lower than low-dose aspirin for chronic therapy (though risk rises with higher doses and long use). Taking with food or with a PPI can help reduce risk.
- Cardiovascular safety
- Aspirin: at low doses it reduces risk of heart attack or certain strokes in people with established ASCVD or high risk (secondary prevention). In primary prevention, the net benefit is smaller and bleeding risk may outweigh it for many people.
- Ibuprofen: does not provide the same cardioprotective effect as aspirin and, at higher doses or with prolonged use, may increase cardiovascular risk slightly in some people. There is also evidence that ibuprofen can interfere with aspirin’s antiplatelet effect if taken together around the same time.
- Kidney safety
- Both drugs can affect kidney function, especially in older adults, people with CKD, dehydration, heart failure, or those taking certain other meds (like ACE inhibitors or diuretics). Long-term NSAID use raises the risk of sustained kidney problems.
- Bleeding risk and drug interactions
- Aspirin: major bleeding risk (GI bleeding, intracranial bleed) due to its antiplatelet action. Interacts with anticoagulants, other antiplatelets, SSRIs, and some steroids.
- Ibuprofen: also raises bleeding risk, especially with other anticoagulants or high doses, but its risk profile is different because its antiplatelet effect is reversible.
Important interaction note: taking ibuprofen around the same time as aspirin can lessen aspirin’s heart-protective effect. If both are needed, spacing doses (e.g., aspirin first, wait several hours before ibuprofen) is sometimes advised—but this should be guided by a clinician.
- Special populations
- Children and teens: aspirin is avoided in people under 19 due to the risk of Reye syndrome after viral infections.
- Pregnancy: aspirin is generally avoided in pregnancy unless specifically advised by a clinician; ibuprofen is usually avoided in the third trimester due to risks to the fetus (and sometimes discouraged earlier as well depending on circumstances).
- Practical notes for long-term use
- If you’re using aspirin for heart/vascular protection, this should be under clinician oversight, with monitoring for bleeding signs and GI protection strategies if risk is high.
If you’re using ibuprofen for chronic pain, aim for the lowest effective dose and shortest duration; avoid long-term high-dose use if possible, and monitor blood pressure, kidney function, and GI symptoms.
For either drug, use alternatives (e.g., acetaminophen, topical agents, non-pharmacologic options) when appropriate, especially if you have a history of ulcers, kidney disease, or are on blood thinners.
Bottom line
- Aspirin: higher GI bleed risk with long-term use; irreversible antiplatelet effect; potential CV benefits in certain people but bleeding risk can outweigh benefit for primary prevention.
- Ibuprofen: GI and kidney risks with long-term use; no cardiac-protective antiplatelet effect; risk considerations differ and there’s less concern about irreversible platelet inhibition.
If you’re considering long-term use of either drug, or you’re taking other medicines (anticoagulants, newer NSAIDs, or have kidney/ulcer history), talk with a clinician to weigh benefits and risks for your specific situation.